There are many oral and injectable options now that are FDA-approved, so its best to stick with medications that have been assessed by the standard safety/efficacy channels. If you do decide to use a compounded medication, make sure you work with a qualified medical provider
In most current discussions, GLP-3 refers to retatrutide, also known by the development code LY3437943
At MFX, in collaborative work done with AstraZeneca Sweden in 2024, co-conducted by Nicholas Akosa (MFX Head of Fields Applications), we demonstrate successful & comparable expansion & phenotype as well as higher viability of T-regs in our low-volume MFX-12 bioreactor vs
Research site Location 1031 Office Park Road Suite 9, West Des Moines, Iowa, United States of America Site insights Top conditions Top treatments Hydrocodone Bitartrate Lubiprostone HYD Fentanyl Lasmiditan Buprenorphine Tirzepatide Tanezumab RTA 901 LY573144 Curious how this site stacks up to its peers
doi: 10.1155/2017/8286248